Skip to content

Other ways to search: Events Calendar | UTHSC News

Vice Chancellor for Research

Dr. Goodman

Steven R. Goodman, PhD became the Vice Chancellor for Research at the University of Tennessee Health Science Center (UTHSC) effective July 27, 2015. Dr. Goodman is also a Professor in the Department of Pediatrics and the Department of Physiology in the College of Medicine, as well as holding Professorships in the Colleges of Pharmacy, Nursing, Health Professions, Dentistry and Graduate Health Sciences at UTHSC. Dr. Goodman led the production of the UTHSC Operational Strategic Plan for Research, the Allocation of Research Space Plan, and Business Plans for all Institutional Research Cores.  VCR Goodman established the innovative Collaborative Research Network (CORNET) awards which has provided pilot funds to new interdisciplinary teams of researchers who cross College and Institutional boundaries. The CORNET awards have produced over $25 million in new grants and contracts with a return on investment of greater than 10/1. He provided the vision for the Memphis Institute of Regenerative Medicine (MIRM).  Dr. Goodman also led the creation of the Clinical Trials Network of Tennessee (CTN2) and serves as the President and CEO of CTN2. Dr. Goodman has helped UTHSC exceed $100 million in annual grants and contracts for the first time in its history.

Dr. Goodman is the former Vice President for Research and Dean of the College of Graduate Studies at SUNY Upstate Medical University, where he also served as Professor in the Departments of Biochemistry and Molecular Biology and Pediatrics. In his prior role as VPR for Research at SUNY Upstate Medical University his entrepreneurial activity included hiring an Associate VP for Industry Relations, establishing a Tech Transfer Office (TTO) and hiring its Director, launching a process and patent committee to handle New Technology Disclosures, and Co-Chairing the Board for the new BioAccelerator called the Central New York BioAccelerator (CNY BAC) and hiring its Executive Director. The new CNY BAC, which Dr. Goodman helped design, houses over twenty startup companies. He also created and directed the International Institute of Biomedical Sciences and Technology (IIBMST).

While at SUNY, Dr. Goodman helped create two additional research collaborations. SUNY REACH, a highly successful research collaboration between the SUNY Academic Health Centers and College of Optometry, served as the model for the current SUNY Network of Excellence in Health. The Hill Collaboration in Environmental Medicine was the shared vision of the Vice Presidents for Research for SUNY Upstate Medical University, Syracuse University, SUNY ESF and the Syracuse VA Medical Center. Dr. Goodman directed SUNY REACH and co-directed the Hill Collaboration.

Dr. Goodman arrived in New York from the University of Texas at Dallas where he served as the C.L. and Amelia A. Lundell Professor of Life Sciences, Professor and Head of the Department of Molecular and Cell Biology, Director of the Institute of Biomedical Sciences and Technology (IBMST), and Director of the Sickle Cell Disease Research Center. He was also an adjunct Professor in the Department of Cell Biology at UT Southwestern Medical Center. Together with Dr. George Buchanan and other colleagues at UT Southwestern Medical Center, Dr. Goodman helped bring the first NIH Sickle Cell Center to Texas. Prior to his positions in Dallas, Dr. Goodman was chair of the Department of Cell Biology and Neuroscience and Director of the NIH Comprehensive Sickle Cell Center at the University of South Alabama College of Medicine.

Dr. Goodman is respected worldwide for his four decades of research into the structure and function of cell structures called membrane skeletons. His related research into sickle cell disease led to defining the molecular basis of the irreversibly sickled cell and his recent proteomic studies led to potential biomarkers for sickle cell severity. He has published over 160 peer-reviewed research articles, review articles, book chapters and books and over 130 scientific meeting abstracts. His research has garnered approximately $20 million of extramural support. He is a past President of the Association of Anatomy, Cell Biology and Neurobiology Chairs (AACBNC), a recipient of the Society of Experimental Biology and Medicine (SEBM) Distinguished Scientist Award, and a recently elected American Association for the Advancement of Science (AAAS) Fellow. The fourth edition of his textbook, Goodman's Medical Cell Biology, was published in July 2020.

Dr. Goodman serves on multiple editorial boards and has been Editor-in-Chief of Experimental Biology and Medicine (EBM) since July 2006. Since becoming Editor-in-Chief of EBM, Dr. Goodman has globalized SEBM and EBM, opening offices in Tainan, Taiwan, London, Great Britain, Chengdu, China, Campinas, Brazil and most recently Ghana Africa. These are in addition to the SEBM office in the Washington DC area and the EBM office in New York City.






May 26, 2022